vaccinejihad
chemotherapy
medicalextremism
dangerousmedicine
medicalviolence
bigpharmanews
News & Articles By Willow Tohi
02/04/2026
/
By Willow Tohi
A cascade of compromises: Cholesterol drug recalls expose systemic flaws
More than 30,000 bottles and cartons of two widely prescribed cholesterol medications, Rosuvastatin and Icosapent Ethyl, have been recalled nationwide. The recalls, initiated by manufacturers AvKARE and Zydus Pharmaceuticals, are due to critical quality failures: one drug fails to dissolve properly, and the other is sub-potent. These failures mean the medications may not work as […]
02/01/2026
/
By Willow Tohi
The fungal frontier: Reexamining an ancient mushroom for modern brain health
Lion’s mane mushroom contains unique compounds, hericenones and erinacines, that stimulate nerve growth factor synthesis, supporting brain cell regeneration. Research indicates potential benefits for cognitive function, including memory, though clinical trial results in humans have been mixed. The mushroom offers broad health support, positively impacting immune function and gut health, and providing potent antioxidant and […]
01/30/2026
/
By Willow Tohi
Medicare to negotiate prices on 15 of the most expensive medications
Medicare will begin price negotiations on 15 high-cost drugs, including Botox and Trulicity, in its third round of talks. The negotiations, authorized by the 2022 Inflation Reduction Act, target drugs accounting for $27 billion in annual Medicare spending. Negotiated prices from this round will take effect in 2028, following a process that includes manufacturer agreements […]
01/28/2026
/
By Willow Tohi
The prescribing cascade: When medications create new “diseases”
A “prescribing cascade” occurs when a drug’s side effects are mistaken for a new illness, leading to unnecessary additional prescriptions. A recent study found only 4% of doctors correctly identified the drug gabapentin as the cause of new leg swelling in patients, most instead prescribing diuretics. This phenomenon is widespread, affecting many common drug classes […]
01/10/2026
/
By Willow Tohi
The needle and the damage done: The risky rise of DIY peptide injections
A growing number of young men are using unregulated, injectable peptides purchased online for aesthetic and performance goals, driven by social media trends. These compounds, distinct from FDA-approved peptide drugs, lack clinical safety data and are not approved for muscle gain or injury recovery. Medical experts warn of significant risks including contamination, hormonal imbalances and […]
01/07/2026
/
By Willow Tohi
Metabolic manipulation: Researchers explore how to make cells safely burn more calories
Researchers have developed new “mild” mitochondrial uncoupler compounds designed to safely increase cellular calorie burn. These compounds work by making mitochondria less efficient, causing cells to use more energy, a principle historically used by the dangerous weight-loss drug DNP. The new molecules are chemically engineered to fine-tune this uncoupling effect, avoiding the severe toxicity and […]
01/03/2026
/
By Willow Tohi
A new front in the drug war: “Rhino Tranq” emerges in California
A new veterinary tranquilizer called medetomidine, far stronger than its predecessor xylazine, has been linked to four overdose deaths in California. The drug, often mixed with fentanyl, causes severe sedation, life-threatening withdrawal requiring ICU care, and is not reversed by standard overdose treatments. The emergence of medetomidine represents an escalation in a drug supply already […]
12/26/2025
/
By Willow Tohi
The skinny jab becomes a swallowable pill: A new era and old concerns
The FDA has approved the first oral version of the blockbuster weight-loss drug Wegovy, a daily pill from Novo Nordisk. Clinical trials show the pill achieves weight loss comparable to the injectable version, averaging 16.6% body weight reduction. The approval intensifies competition in the lucrative obesity drug market, projected to be worth $100 billion annually. […]
12/09/2025
/
By Willow Tohi
A VICTORY for informed consent: CDC panel reverses decades-old newborn vaccine policy
A CDC advisory panel voted to end the universal recommendation that all newborns receive a hepatitis B vaccine within 24 hours of birth. For infants born to mothers who test negative for hepatitis B, the decision is now one of “individual-based decision-making” between parents and doctors. The change follows scrutiny of the vaccine’s necessity for […]
12/06/2025
/
By Willow Tohi
Health Freedom vs. The Mandate: $8B Vaccine industry fights to keep injecting every American at birth
The CDC’s vaccine advisory panel is poised to vote on a proposal to end the universal hepatitis B vaccine birth dose for infants of negative-testing mothers. A preemptive media and op-ed campaign, led by former health officials, warns this change could reverse decades of progress, predicting a modest increase in infant infections. Critics argue the […]
« Previous Page
5 of 17
Next Page »
Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected.
Subscription confirmation required.
Popular Articles
Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Subscription confirmation required.
We respect your privacy
and do not share emails with anyone. You can easily unsubscribe at any time.
COPYRIGHT © 2017 BIG PHARMA NEWS
Privacy Policy
Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Subscription confirmation required.
We respect your privacy
and do not share emails with anyone. You can easily unsubscribe at any time.
Close
x
By continuing to browse our site you agree to our use of cookies and our
Privacy Policy
.
Agree and close